Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Earnings for Fagron NV (FAGR.BR)
Earnings in 2023 (TTM): $89.08 M
According to Fagron NV's latest financial reports the company's current earnings (TTM) are $89.08 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Fagron NV
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $89.08 M | $74.42 M |
| 2022 | $92.59 M | $73.43 M |
| 2021 | $81.04 M | $64.35 M |
| 2020 | $77.76 M | $62.87 M |
| 2019 | $73.72 M | $58.74 M |
| 2018 | $57.85 M | $44.82 M |
| 2017 | $59.04 M | $49.22 M |
| 2016 | $-6,713,450 | $-21,691,070 |
| 2015 | $-206,054,612 | $-213,437,931 |
| 2014 | $73.69 M | $17.12 M |
| 2013 | $55.47 M | $-33,864,737 |
| 2012 | $45.5 M | $46.32 M |
| 2011 | $39.11 M | $29.69 M |
| 2010 | $31.71 M | $23.71 M |
| 2009 | $24.38 M | $20.72 M |
| 2008 | $18.97 M | $15.72 M |
| 2007 | $20.51 M | $17.15 M |
| 2006 | $15.41 M | $12.79 M |
| 2005 | $20.89 M | $15.89 M |
| 2004 | $21.78 M | $14.56 M |